Segall Bryant & Hamill’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.4M Sell
428,507
-57,502
-12% -$3.45M 0.32% 98
2025
Q4
$28.6M Sell
486,009
-44,912
-8% -$2.73M 0.39% 73
2025
Q3
$29.5M Sell
530,921
-34,680
-6% -$1.86M 0.39% 71
2025
Q2
$29.1M Buy
565,601
+48,838
+9% +$2.45M 0.41% 68
2025
Q1
$30.3M Sell
516,763
-8,246
-2% -$559K 0.46% 58
2024
Q4
$37.8M Buy
525,009
+47,129
+10% +$3.46M 0.52% 44
2024
Q3
$38.2M Buy
477,880
+72,011
+18% +$5.41M 0.52% 44
2024
Q2
$29.1M Buy
405,869
+125,299
+45% +$9.22M 0.52% 57
2024
Q1
$19.7M Sell
280,570
-11,743
-4% -$840K 0.37% 95
2023
Q4
$22.6M Sell
292,313
-576,987
-66% -$38M 0.43% 72
2023
Q3
$59.2M Sell
869,300
-70,546
-8% -$5.57M 0.68% 30
2023
Q2
$76.7M Sell
939,846
-18,361
-2% -$1.48M 0.8% 21
2023
Q1
$71.1M Buy
958,207
+2,386
+0.2% +$184K 0.77% 24
2022
Q4
$79.2M Sell
955,821
-2,347
-0.2% -$186K 0.88% 18
2022
Q3
$68M Buy
958,168
+89,204
+10% +$7.71M 0.81% 21
2022
Q2
$75.3M Sell
868,964
-33,120
-4% -$3.1M 0.85% 22
2022
Q1
$97.7M Buy
902,084
+16,580
+2% +$1.71M 0.93% 22
2021
Q4
$115M Sell
885,504
-25,428
-3% -$3.12M 1.06% 17
2021
Q3
$110M Sell
910,932
-32,696
-3% -$3.98M 1.06% 17
2021
Q2
$106M Sell
943,628
-19,316
-2% -$2.03M 1.03% 17
2021
Q1
$91.9M Sell
962,944
-86,664
-8% -$7.91M 0.91% 20
2020
Q4
$83.4M Buy
1,049,608
+51,388
+5% +$3.72M 0.93% 19
2020
Q3
$61.8M Buy
998,220
+73,292
+8% +$4.77M 0.84% 24
2020
Q2
$61M Sell
924,928
-82,252
-8% -$4.93M 1.03% 17
2020
Q1
$47.7M Sell
1,007,180
-27,748
-3% -$1.39M 0.97% 19
2019
Q4
$56.8M Sell
1,034,928
-82,208
-7% -$4.31M 0.88% 25
2019
Q3
$54.7M Buy
1,117,136
+33,160
+3% +$1.66M 0.85% 21
2019
Q2
$56.5M Sell
1,083,976
-13,292
-1% -$670K 0.85% 21
2019
Q1
$54.5M Buy
1,097,268
+35,576
+3% +$1.6M 0.85% 19
2018
Q4
$38.4M Sell
1,061,692
-41,128
-4% -$1.72M 0.66% 34
2018
Q3
$56.3M Sell
1,102,820
-354,536
-24% -$15.7M 0.83% 18
2018
Q2
$53.9M Buy
1,457,356
+214,628
+17% +$8.2M 0.82% 19
2018
Q1
$46.9M Sell
1,242,728
-144,732
-10% -$5.11M 1.09% 21
2017
Q4
$44.9M Sell
1,387,460
-441,408
-24% -$14M 0.99% 27
2017
Q3
$55.3M Sell
1,828,868
-372,772
-17% -$11.1M 1.28% 14
2017
Q2
$64.7M Sell
2,201,640
-81,772
-4% -$2.24M 1.52% 7
2017
Q1
$58M Buy
2,283,412
+35,924
+2% +$927K 1.4% 9
2016
Q4
$57.8M Sell
2,247,488
-162,328
-7% -$4.26M 1.45% 8
2016
Q3
$66M Sell
2,409,816
-16,760
-0.7% -$460K 1.69% 3
2016
Q2
$68.4M Sell
2,426,576
-422,856
-15% -$10.9M 1.8% 2
2016
Q1
$67.3M Sell
2,849,432
-186,536
-6% -$4.11M 1.67% 3
2015
Q4
$68.3M Sell
3,035,968
-13,252
-0.4% -$302K 1.64% 3
2015
Q3
$70.5M Sell
3,049,220
-24,444
-0.8% -$613K 1.72% 1
2015
Q2
$75.7M Buy
3,073,664
+74,328
+2% +$1.86M 1.69% 1
2015
Q1
$75.2M Buy
2,999,336
+57,900
+2% +$1.38M 1.69% 1
2014
Q4
$67.9M Buy
2,941,436
+37,748
+1% +$864K 1.53% 3
2014
Q3
$67.9M Sell
2,903,688
-156,456
-5% -$3.67M 1.57% 2
2014
Q2
$70.8M Buy
3,060,144
+246,576
+9% +$5.45M 1.69% 2
2014
Q1
$60M Buy
2,813,568
+1,101,528
+64% +$24.8M 1.43% 6
2013
Q4
$40.5M Buy
1,712,040
+913,552
+114% +$19.8M 0.94% 20
2013
Q3
$16M Buy
798,488
+786,488
+6,554% +$14.9M 0.39% 81
2013
Q2
$207K Buy
+12,000
New +$199K 0.01% 518

Other funds holding TECH

Segall Bryant & Hamill's TECH Position: Q1 2026 in Review

Segall Bryant & Hamill reduced its Bio-Techne (TECH) stake by 12% in Q1 2026, selling an estimated $3.45M and leaving 428,507 shares worth $22.4M. The position accounts for 0.32% of the portfolio, ranked #98.

Segall Bryant & Hamill first reported a position in TECH in Q2 2013 and has held it in 52 quarters since. The position peaked at $115M in Q4 2021. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Segall Bryant & Hamill held 428,507 shares of Bio-Techne worth $22.4M as of Q1 2026.
  • Segall Bryant & Hamill sold 57,502 Bio-Techne shares in Q1 2026, an estimated $3.45M.
  • Bio-Techne made up 0.32% of Segall Bryant & Hamill's portfolio in Q1 2026, its #98 holding.
  • Segall Bryant & Hamill first reported a position in Bio-Techne in Q2 2013 and has held it in 52 quarters since.
  • Segall Bryant & Hamill's Bio-Techne position peaked at $115M in Q4 2021.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Segall Bryant & Hamill's 13F filing for Q1 2026, filed 15 May 2026.